Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

Quinidine sulfate dihydrate

Base Information Edit
  • Chemical Name:Quinidine sulfate dihydrate
  • CAS No.:6591-63-5
  • Deprecated CAS:60553-86-8
  • Molecular Formula:2C20H24N2O2*8H2O*H2O4S
  • Molecular Weight:891.047
  • Hs Code.:2939200050
  • European Community (EC) Number:200-046-3,678-472-8
  • UNII:J13S2394HE
  • DSSTox Substance ID:DTXSID101017271
  • Wikidata:Q27281012
  • NCI Thesaurus Code:C48014
  • RXCUI:9069
  • Pharos Ligand ID:FVG9PYTL7D4N
  • ChEMBL ID:CHEMBL3707183
  • Mol file:6591-63-5.mol
Quinidine sulfate dihydrate

Synonyms:(S)-[(4S,5R,7R)-5-Ethenyl-1-azabicyclo[2.2.2]octan-7-yl]-(6-methoxyquinolin-4-yl)methanol sulfate dihydrate

Suppliers and Price of Quinidine sulfate dihydrate
Supply Marketing:Edit
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • Usbiological
  • Quinidine Sulfate
  • 1g
  • $ 403.00
  • TRC
  • Quinidinesulfatedihydrate
  • 2.5g
  • $ 45.00
  • TRC
  • Quinidinesulfatedihydrate
  • 25g
  • $ 175.00
  • Sigma-Aldrich
  • Quinidine sulfate European Pharmacopoeia (EP) Reference Standard
  • $ 190.00
  • Sigma-Aldrich
  • Quinidine sulfate salt dihydrate
  • 25g
  • $ 190.00
  • Sigma-Aldrich
  • Quinidine sulfate European Pharmacopoeia (EP) Reference Standard
  • q0100000
  • $ 190.00
  • Sigma-Aldrich
  • Quinidine sulfate United States Pharmacopeia (USP) Reference Standard
  • 500mg
  • $ 366.00
  • Sigma-Aldrich
  • Quinidine sulfate salt dihydrate
  • 50g
  • $ 349.00
  • Sigma-Aldrich
  • Quinidine sulfate salt dihydrate
  • 10g
  • $ 88.80
  • Medical Isotopes, Inc.
  • QuinidineSulfateDihydrate
  • 1 g
  • $ 610.00
Total 55 raw suppliers
Chemical Property of Quinidine sulfate dihydrate Edit
Chemical Property:
  • Appearance/Colour:white to light yellow crystal powde 
  • Vapor Pressure:0mmHg at 25°C 
  • Melting Point:212-214 ºC (dec.) 
  • Refractive Index:275 ° (C=2, 0.1mol/L HCl) 
  • Boiling Point:992.5°C at 760 mmHg 
  • Flash Point:554°C 
  • PSA:192.62000 
  • LogP:6.52160 
  • Storage Temp.:under inert gas (nitrogen or Argon) at 2-8°C 
  • Sensitive.:Light Sensitive 
  • Solubility.:Slightly soluble in water, soluble in boiling water and in ethanol (96 per cent), practically insoluble in acetone. 
  • Water Solubility.:Soluble in chloroform, water (11 mg/ml at 20°C), alcohol, and ethanol (50 mg/ml). 
  • Hydrogen Bond Donor Count:6
  • Hydrogen Bond Acceptor Count:14
  • Rotatable Bond Count:8
  • Exact Mass:782.35606511
  • Heavy Atom Count:55
  • Complexity:538
Purity/Quality:

98%,99%, *data from raw suppliers

Quinidine Sulfate *data from reagent suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes:Xn 
  • Statements: 22-20/21/22 
  • Safety Statements: 13-36 
MSDS Files:

SDS file from LookChem

Useful:
  • Canonical SMILES:COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O.COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O.O.O.OS(=O)(=O)O
  • Isomeric SMILES:COC1=CC2=C(C=CN=C2C=C1)[C@@H]([C@H]3C[C@@H]4CCN3C[C@@H]4C=C)O.COC1=CC2=C(C=CN=C2C=C1)[C@@H]([C@H]3C[C@@H]4CCN3C[C@@H]4C=C)O.O.O.OS(=O)(=O)O
  • Recent ClinicalTrials:Study of the Electrocardiographic Effects of Ranolazine, Dofetilide, Verapamil, and Quinidine in Healthy Subjects
  • Recent NIPH Clinical Trials:Quinidine sulfate administration for intractable epilepsy with KCNT1 gene mutation
  • Uses Quinidine sulfate dihydrate (cas# 6591-63-5) is the hydrated, sulfate salt of Quinidine (Q685000), a dextrorotatory stereoisomer of Quinine. Antiarrhythmic (class IA). Antimalarial.
  • Clinical Use Quinidine sulfate is the prototype of antiarrhythmicdrugs and a class IA antiarrhythmic agent according to theVaughan Williams classification. It reduces Na+ current bybinding the open ion channels (i.e., state A). The decreasedNa+entry into the myocardial cell depresses phase 4 diastolicdepolarization and shifts the intracellular threshold potentialtoward zero. These combined actions diminish thespontaneous frequency of pacemaker tissues, depress theautomaticity of ectopic foci, and, to a lesser extent, reduceimpulse formation in the SA node. This last action results inbradycardia. During the spike action potential, quinidinesulfate decreases transmembrane permeability to passiveinflux of Na+, thus slowing the process of phase 0 depolarization,which decreases conduction velocity. This is shownas a prolongation of the QRS complex of electrocardiograms.Quinidine sulfate also prolongs action potential duration,which results in a proportionate increase in the QTinterval. It is used to treat supraventricular and ventricularectopic arrhythmias, such as atrial and ventricular prematurebeats, atrial and ventricular tachycardia, atrial flutter, andatrial fibrillation.
Post RFQ for Price